Business Context and Reporting Period
Company: Minerva Neurosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 17, 2022
Reporting Period: Event date of June 17, 2022
The Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect a reverse stock split. This action was approved by stockholders at the 2022 Annual Meeting on June 10, 2022, and by the Board of Directors on the same date.
Key Financial Metrics
This filing is a corporate governance report regarding capital structure and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Reverse Stock Split: A one-for-eight (1-for-8) reverse stock split of outstanding common stock became effective at 5:00 p.m. Eastern Time on June 17, 2022.
- Share Consolidation: Every eight shares of issued and outstanding common stock were automatically combined into one share.
- Equity Adjustments: Proportionate adjustments were made to the per share exercise price and number of shares for outstanding stock options, restricted stock units (RSUs), and restricted stock awards. The number of shares reserved under equity compensation plans was reduced proportionately.
- Fractional Shares: No fractional shares were issued; stockholders entitled to fractional shares received cash payments in lieu thereof.
- Trading Status: Common stock began trading on The Nasdaq Global Market on a split-adjusted basis on June 21, 2022.
- Ownership: The split affects all stockholders proportionately and does not change any stockholder's percentage ownership (except regarding fractional share rounding).
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks beyond the mechanics of the stock split. The primary operational change is the update to the CUSIP number for the common stock to 603380 205.
Investor Verification Checklist
- Verify the new CUSIP number (603380 205) for trading purposes.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Review adjusted exercise prices and share counts for any outstanding stock options or RSUs.
- Check for cash payments received in lieu of fractional shares.
- Monitor trading activity on The Nasdaq Global Market starting June 21, 2022, on a split-adjusted basis.